Literature DB >> 18923656

Current endovascular management of the ischaemic diabetic foot.

T Gerassimidis1, C D Karkos, D Karamanos, A Kamparoudis.   

Abstract

Ischaemic diabetic foot ulcers pose a significant problem which is associated with a high likelihood of amputation. With the advent of endovascular surgery, the management of lower limb arterial lesions in the diabetic population has become more appealing. Coronary 0.014 monorail guide wires, appropriate sized angioplasty balloons and stents, and subintimal recanalisation, are all useful adjuncts and techniques to achieve revascularization. This article reviews the modern endovascular management of the diabetic foot.

Entities:  

Keywords:  diabetic foot; endovascular interventions

Year:  2008        PMID： 18923656      PMCID： PMC2464305     

Source DB:  PubMed          Journal:  Hippokratia        ISSN： 1108-4189            Impact factor:   0.471


  11 in total

1.  COMBINED CLINICAL AND PATHOLOGIC STUDY OF DIABETIC AND NONDIABETIC PERIPHERAL ARTERIAL DISEASE.

Authors:  D E STRANDNESS; R E PRIEST; G E GIBBONS
Journal:  Diabetes       Date:  1964 Jul-Aug       Impact factor: 9.461

2.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes; Kevin Bell; Joseph Caporusso; Isabelle Durand-Zaleski; Kimihiro Komori; Johannes Lammer; Christos Liapis; Salvatore Novo; Mahmood Razavi; Johns Robbs; Nicholaas Schaper; Hiroshi Shigematsu; Marc Sapoval; Christopher White; John White; Denis Clement; Mark Creager; Michael Jaff; Emile Mohler; Robert B Rutherford; Peter Sheehan; Henrik Sillesen; Kenneth Rosenfield
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-11-29       Impact factor: 7.069

Review 3.  Current therapeutic options in the management of superficial femoral artery occlusive disease.

Authors:  Chr D Karkos; D G Karamanos; D N Papadimitriou; D P Malkotsis; F P Demiropoulos; K O Papazoglou; A G Kamparoudis; I E Pezikoglou; Th S Gerassimidis
Journal:  Acta Chir Belg       Date:  2007 Nov-Dec       Impact factor: 1.090

4.  Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity.

Authors:  L Graziani; A Silvestro; V Bertone; E Manara; R Andreini; A Sigala; R Mingardi; R De Giglio
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-12-29       Impact factor: 7.069

5.  Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia.

Authors:  A M Lazaris; C Salas; A C Tsiamis; P A Vlachou; A Bolia; G Fishwick; P R Bell
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-09-11       Impact factor: 7.069

6.  Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.

Authors:  Stephan H Duda; Marc Bosiers; Johannes Lammer; Dierk Scheinert; Thomas Zeller; Vincent Oliva; Alexander Tielbeek; John Anderson; Benjamin Wiesinger; Gunnar Tepe; Alexandra Lansky; Michael R Jaff; Catharina Mudde; Hans Tielemans; Jean-Paul Beregi
Journal:  J Endovasc Ther       Date:  2006-12       Impact factor: 3.487

7.  Diabetes mellitus and atherosclerotic involvement of the profunda femoris artery.

Authors:  T A King; R G DePalma; R S Rhodes
Journal:  Surg Gynecol Obstet       Date:  1984-12

8.  Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study.

Authors:  Nicholas Tentolouris; Sameer Al-Sabbagh; Michael G Walker; Andrew J M Boulton; Edward B Jude
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

Review 9.  The diabetic foot: from art to science. The 18th Camillo Golgi lecture.

Authors:  A J M Boulton
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

10.  Clinical outcome of primary infrainguinal subintimal angioplasty in diabetic patients with critical lower limb ischemia.

Authors:  Andreas M Lazaris; Achilleas C Tsiamis; Guy Fishwick; Amman Bolia; Peter R F Bell
Journal:  J Endovasc Ther       Date:  2004-08       Impact factor: 3.487
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.